Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Dear Editor: Acute myeloid leukemia (AML) originates in the bone marrow (BM), but in some patients, leukemic cells infiltrate peripheral tissues such as the skin (leukemia cutis) or other organs (myeloid sarcoma), a phenomenon known as extramedullary AML (eAML). eAML can present at initial diagnosis, during relapse after chemotherapy or allogeneic hematopoietic cell transplantation (allo-HCT), either in isolation or concurrently with BM involvement [1].
Abstract Extramedullary acute myeloid leukemia (eAML) is a rare form of myeloid neoplasm characterized by leukemic infiltration outside the bone marrow (BM). Despite its prognostic significance, eAML is often underdiagnosed and poorly characterized at molecular level. We performed a comprehensive genomic and immunogenomic profiling on paired BM and extramedullary specimens from 26 eAML patients, alongside over 400 AML cases without extramedullary involvement and 97 healthy controls.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
